Publications by authors named "Marta Hernandez-Ferrandiz"
Background: There are several position statements and clinical practice guidelines (CPG) for diagnosing dementia.
Objective: Our aims were to evaluate the adherence to CPG among specialists in the 7 memory clinics included in the Registry of Dementias of Girona (ReDeGi), and to compare the results between 2007-2011 and 2012-2015. We also determined the time and number of visits required to achieve a diagnosis, the supplementary tests ordered, and the drugs prescribed according to dementia subtypes.
Introduction: The rates of cognitive decline in patients with Alzheimer's disease show variations due to various factors. AIM. To determine the influence of age, education, gender, activities of daily living (ADL) and acetylcholinesterase inhibitors (IAChE) and memantine in the rhythm and rate of cognitive decline.
View Article and Find Full Text PDFBackground: There are discrepant findings regarding which subscales of the Cambridge Cognitive Examination (CAMCOG) are able to predict cognitive decline. The study aimed to identify the baseline CAMCOG subscales that can discriminate between patients and predict cognitive decline in Alzheimer's disease (AD) and mild cognitive impairment (MCI).
Methods: This was a five-year case-control study of patients with cognitive impairment and a control group.
Introduction: The indirect cost associated with the care of patients with Alzheimer's disease is taken on primarily by the family.
Aim: To describe the cost associated with time dedication, its annual evolution, associated characteristics and related caregiver burden.
Subjects And Methods: Non-institutionalized patients diagnosed with Alzheimer's disease who are managed on an out-patient basis in a diagnosis unit and their primary caregivers.
Objectives: To identify patient groups with Alzheimer disease (AD) according to the presence of psychological and behavioral syndromes and to determine the clinical differences among these groups.
Methods: Cross-sectional and observational study of 491 patients with probable AD whom were administered the Neuropsychiatric Inventory (NPI) at the baseline visit and reevaluated after 12 months.
Results: Principal component analysis (PCA) of baseline NPI data revealed three factors, including a psychosis factor (delusions, hallucinations, and aberrant motor behavior), a depressive factor (depression, anxiety, irritability, agitation, and apathy) and a hypomanic factor (euphoria and disinhibition).
Objective: The neuropsychological assessment of patients with fibromyalgia (FM) and with subjective cognitive complaints was analyzed. The group was compared with a mild cognitive impairment (MCI) group without FM.
Material And Method: Retrospective study of 32 patients with FM were evaluated and 86 patients with MCI without FM.
Objective: Data in the literature show different estimates of the prevalence of depression in patients with Alzheimer disease (AD) when different classification systems are used. This study describes the prevalence and clinical features of depression in AD based on five different depression classification systems.
Methods: This was a cross-sectional, observational study of 491 patients with probable AD.
Background And Objective: This study aims to identify the relationship between costs of medical and social attention in patients with dementia of Alzheimer disease (AD) type and clinical and sociodemographic data of patients and their caregivers.
Patients And Method: It was an analytic observational study in a cohort of patients diagnosed with Alzheimer's disease who received ambulatory attention. Information about the use of health-related resources was collected and costs were estimated from a societal perspective.